Just saw that the CFO of Disc Medicine dumped like $720k worth of shares last month. Sold over 11k shares across two days in mid-February, which was actually way more than anything they've done before. That's gotta be a red flag, right?

Makes sense though when you think about what happened to the company. Their main drug bitopertin got rejected by the FDA in mid-February, and it was supposed to treat some rare blood disorder. The FDA basically said the trial data wasn't convincing enough and they were worried about abuse potential. Pretty brutal for a biotech company betting on that approval.

Since then it's been rough - stock is down like 15% this year, they cut 20% of their workforce at the end of February, and their earnings report showed their losses actually doubled year-over-year. So the CFO selling that chunk of their stake right after all this went down definitely feels like someone getting out while they can. Not exactly a vote of confidence in the recovery plan, you know?